thumbnail
Therapeutic ClassGLP-1 boom causing pharma players FOMOGLP-1 boom causing pharma players FOMO
Industry experts at Bio-Europe Spring congratulated Eli Lilly and Novo Nordisk for persisting in the GLP-1 space and discussed how the next wave of innovation is not always clear.